Fentanyl Citrate Injection Formulations UK: The History Of Fentanyl Citrate Injection Formulations UK In 10 Milestones

Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview

Fentanyl citrate remains one of the most crucial tools in modern-day anaesthesia and sharp pain management throughout the United Kingdom. As a potent synthetic opioid, its role in the National Health Service (NHS) and private surgical sectors is well-established, mostly due to its quick start of action and cardiovascular stability. This post provides a thorough summary of fentanyl citrate injection solutions offered in the UK, their medical indicators, regulatory landscape, and administration procedures.

What is Fentanyl Citrate?

Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was very first synthesized in 1960 and rapidly ended up being a cornerstone of perioperative care. In terms of effectiveness, fentanyl is around 50 to 100 times more potent than morphine. Its high lipophilicity allows it to cross the blood-brain barrier rapidly, resulting in a nearly immediate analgesic result when administered intravenously.

In the UK, fentanyl citrate is mainly utilized via the parenteral route (injection) for both sedative and analgesic functions. It works primarily by binding to the mu-opioid receptors in the main nervous system, modifying the understanding of discomfort and the emotional action to it.

Scientific Indications in the UK

According to the British National Formulary (BNF), fentanyl citrate injection is indicated for numerous specific medical circumstances:

  • Analgesic Action: Used during short operative procedures and in the healing room.
  • Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
  • Neuroleptanalgesia: Often utilized in combination with a neuroleptic (such as droperidol) to attain a state of quiescence and minimized awareness.
  • Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for clients on mechanical ventilation.
  • Pre-medication: To provide sedation and analgesia before the induction of basic anaesthesia.

Offered Formulations and Strengths in the UK

The UK market offers several formulations of fentanyl citrate, developed to meet the differing needs of surgical and emergency situation departments. learn more are usually presented as clear, colourless solutions for injection or infusion.

Table 1: Common Fentanyl Citrate Formulations in the UK

Strength (Fentanyl base)

Presentation

Typical Packaging

Maker Examples

50 micrograms/ml

2 ml Ampoule

Load of 10

Hameln, Advanz Pharma

50 micrograms/ml

10 ml Ampoule

Pack of 5 or 10

Hameln, Wockhardt

50 micrograms/ml

20 ml Vial/Ampoule

Pack of 5

Hameln, Generic

50 micrograms/ml

50 ml Vial

Individual/Pack of 1

Generic (ICU use)

Note: While 50 mcg/ml is the basic concentration, specialised formulas for epidural or intrathecal usage may sometimes be prepared by medical facility pharmacies under specific procedures.

Pharmacokinetics and Pharmacodynamics

Comprehending how the body processes fentanyl is essential for safe administration.

  1. Start of Action: When administered intravenously, the effect begins practically immediately, though the optimum analgesic result may take 3 to 5 minutes.
  2. Period: A single intravenous dose of 100 micrograms generally lasts for 30 to 60 minutes.
  3. Metabolism: Fentanyl is mainly metabolised in the liver by means of the CYP3A4 enzyme system.
  4. Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, mainly as metabolites.

Administration Protocols

In the UK, the administration of fentanyl citrate is strictly managed and usually carried out by anaesthetists or trained practitioners in controlled environments.

Dosage Guidelines

Dose needs to be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.

  • Low Dose (2 mcg/kg): Useful for small surgical procedures.
  • Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; needs breathing monitoring.
  • High Dose (20-- 50 mcg/kg): Used throughout "trouble-free" major surgeries (e.g., open-heart surgery) to secure the myocardium from the metabolic demands of stress.

Paths of Administration

  • Intravenous (IV) Bolus: Common for induction.
  • Intravenous Infusion: Used for longer procedures or in the ICU.
  • Intramuscular (IM): Less common, but used for pre-medication in specific circumstances.

Regulatory Status and Safety

In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).

Statutory Requirements for UK Hospitals:

  • Safe Custody: Must be saved in a locked managed drug cabinet.
  • Record Keeping: Every administration must be taped in a Controlled Drugs Register (CDR).
  • Destruction: Surplus or ended fentanyl should be denatured and experienced by authorised personnel.

Side Effects and Adverse Reactions

While extremely reliable, fentanyl citrate brings a danger of substantial side effects.

  • Respiratory Depression: The most serious adverse effects, which can result in breathing arrest if not monitored.
  • Bradychardia: Often managed with atropine.
  • Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation difficult, requiring making use of neuromuscular blocking agents.
  • Queasiness and Vomiting: Common in the postoperative period.
  • Hypotension: Although more steady than morphine, it can still happen, particularly in hypovolaemic patients.

Contrast with Other Opioids

Clinicians typically choose fentanyl over other opioids due to its particular pharmacokinetic profile.

Table 2: Comparison of Parenteral Opioids in UK Practice

Feature

Fentanyl

Morphine

Remifentanil

Relative Potency

100

1

100-200

Onset

1-- 3 minutes

15-- 30 minutes

1 minute

Period of Action

30-- 60 minutes

3-- 4 hours

5-- 10 minutes

Histamine Release

Negligible

Substantial

Negligible

Primary Use

Intraoperative/ICU

Post-operative/Chronic

Titratable Infusion

Regularly Asked Questions (FAQ)

1. Is fentanyl citrate injection the like the fentanyl patches?

No. While they contain the exact same active drug, the injection is for immediate, severe use in surgical or emergency settings. Patches (transdermal shipment) are created for chronic, long-lasting discomfort management and release the medication slowly over 72 hours.

2. Can fentanyl citrate be used for children in the UK?

Yes, it is often used in paediatric anaesthesia. However, learn more must be strictly determined based on the kid's weight, and they should be kept an eye on carefully for breathing anxiety.

3. What is the antagonist for fentanyl?

Naloxone is the particular medicinal villain utilized to reverse the results of fentanyl, consisting of breathing anxiety. In UK healthcare facilities, naloxone needs to constantly be easily available anywhere fentanyl is administered.

4. Why is it utilized over morphine in heart surgery?

Fentanyl is chosen in heart surgical treatment because it does not cause the release of histamine, which can result in vasodilation and hypotension. It offers cardiovascular stability even at high dosages.

5. What are the storage requirements?

Fentanyl citrate injection need to be saved listed below 25 ° C and safeguarded from light. As a Schedule 2 drug, it needs to be kept in a lawfully certified CD cupboard.

Fentanyl citrate injection solutions are vital elements of the UK's medical toolkit for managing perioperative discomfort and helping with intricate surgical treatments. Its high strength and fast start deal unequaled accuracy for anaesthetists, provided that rigorous monitoring and regulatory standards are maintained. By comprehending the various concentrations and the stringent procedures surrounding its usage, health care specialists ensure that this effective medication stays both safe and efficient for patients throughout the nation.


Disclaimer: This short article is for educational functions just and does not make up medical suggestions. Health care professionals should constantly refer to the Summary of Product Characteristics (SmPC) and current BNF standards for the most current prescribing details.

Edit

Pub: 17 May 2026 22:57 UTC

Views: 0